cadenas
  • Innovative Therapies
    for Children with Cancer in Europe
  • Contact us

Solid Tumor

  • A multicentre, open-label, randomised, Phase 2 study to compare the efficacy and safety of lenvatinib (LEN) in combination with ifosfamide (IFO) and etoposide (ETO) versus IFO and ETO in subjects...

  • An Open-Label, Single-Arm, Phase 1/2 Study Evaluating the Safety and Efficacy of Single- Agent Ponatinib for the Treatment of advanced Leukemias or Solid Tumors in Pediatric Participants

  • A Phase 1 Study of Aurora Kinase A Inhibitor LY3295668 Erbumine as a Single Agent and in Combination in Patients With Relapsed/Refractory Neuroblastoma

  • A Phase 1b, Dose Escalation Study of Abemaciclib in Combination with Temozolomide and Irinotecan (triplet escalation) and Abemaciclib in combination with Temozolomidea

  • A Study of Oral LOXO-292 in Pediatric Patients With Advanced Solid or Primary Central Nervous System Tumors

  • A Randomized, Open-Label Phase 1/2 Study Evaluating Ramucirumab in Pediatric Patients and Young Adults with Relapsed, Recurrent, or Refractory Desmoplastic Small Round Cell Tumor

  • A Randomized, Open-Label Phase 1/2 Study Evaluating Ramucirumab in Pediatric Patients and Young Adults with Relapsed, Recurrent, or Refractory Synovial Sarcoma

  • ITCC-091 FaR-RMS

    Solid Tumor

    FaR-RMS: An overarching study for children and adults with Frontline and Relapsed RhabdoMyoSarcoma

17 - 24 sur 24
<< Premier 1 2 3 Suivant > Dernier >>